NO954583D0 - Blanding for oral administrering - Google Patents

Blanding for oral administrering

Info

Publication number
NO954583D0
NO954583D0 NO954583A NO954583A NO954583D0 NO 954583 D0 NO954583 D0 NO 954583D0 NO 954583 A NO954583 A NO 954583A NO 954583 A NO954583 A NO 954583A NO 954583 D0 NO954583 D0 NO 954583D0
Authority
NO
Norway
Prior art keywords
drug
release
composition
colon
plasma levels
Prior art date
Application number
NO954583A
Other languages
English (en)
Other versions
NO306759B1 (no
NO954583L (no
Inventor
Lisbeth Illum
Peter Watts
Nidal Farraj
Original Assignee
Danbiosyst Uk Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Danbiosyst Uk Ltd filed Critical Danbiosyst Uk Ltd
Publication of NO954583D0 publication Critical patent/NO954583D0/no
Publication of NO954583L publication Critical patent/NO954583L/no
Publication of NO306759B1 publication Critical patent/NO306759B1/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4808—Preparations in capsules, e.g. of gelatin, of chocolate characterised by the form of the capsule or the structure of the filling; Capsules containing small tablets; Capsules with outer layer for immediate drug release
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5084—Mixtures of one or more drugs in different galenical forms, at least one of which being granules, microcapsules or (coated) microparticles according to A61K9/16 or A61K9/50, e.g. for obtaining a specific release pattern or for combining different drugs

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
NO954583A 1993-05-29 1995-11-14 Blanding for oral administrering NO306759B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB939311191A GB9311191D0 (en) 1993-05-29 1993-05-29 Controlled release drug formulation
PCT/GB1994/001158 WO1994027582A1 (en) 1993-05-29 1994-05-27 A drug delivery composition for alpha-adreno receptor blocking agents

Publications (3)

Publication Number Publication Date
NO954583D0 true NO954583D0 (no) 1995-11-14
NO954583L NO954583L (no) 1995-11-14
NO306759B1 NO306759B1 (no) 1999-12-20

Family

ID=10736382

Family Applications (1)

Application Number Title Priority Date Filing Date
NO954583A NO306759B1 (no) 1993-05-29 1995-11-14 Blanding for oral administrering

Country Status (12)

Country Link
EP (1) EP0700285B1 (no)
JP (1) JPH09504779A (no)
AT (1) ATE171370T1 (no)
AU (1) AU684786B2 (no)
CA (1) CA2163340A1 (no)
DE (1) DE69413534T2 (no)
DK (1) DK0700285T3 (no)
ES (1) ES2124889T3 (no)
FI (1) FI955730A (no)
GB (2) GB9311191D0 (no)
NO (1) NO306759B1 (no)
WO (1) WO1994027582A1 (no)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6166024A (en) 1995-03-30 2000-12-26 Mayo Foundation For Medical Education And Research Use of topical azathioprine and thioguanine to treat colorectal adenomas
FR2752737B1 (fr) * 1996-08-29 1998-10-02 Synthelabo Comprime a liberation controlee de chlorhydrate d'alfuzosine
US6149940A (en) * 1996-08-29 2000-11-21 Synthelabo Tablet with controlled release of alfuzosine chlorhydrate
UA74141C2 (uk) 1998-12-09 2005-11-15 Дж.Д. Сірл Енд Ко. Фармацевтична композиція на основі тонкоподрібненого еплеренону (варіанти), спосіб її одержання та спосіб лікування розладів, опосередкованих альдостероном (варіанти)
US6749867B2 (en) 2000-11-29 2004-06-15 Joseph R. Robinson Delivery system for omeprazole and its salts
FR2820318B1 (fr) * 2001-02-08 2005-12-23 Ellipse Pharmaceuticals Procede de fabrication d'un comprime flottant incluant un principe actif et comprime obtenu
FR2820319B3 (fr) * 2001-02-08 2003-12-05 Ellipse Pharmaceuticals Procede de fabrication d'un comprime flottant incluant de l'alfuzosine et comprime obtenu
EP1366761A4 (en) * 2001-02-13 2004-04-21 Taisho Pharmaceutical Co Ltd GEL PREPARATIONS FOR INTERNAL USE
BR0315569A (pt) * 2002-10-22 2005-08-30 Ranbaxy Lab Ltd Apresentação farmacêutica de liberação prolongada contendo alfuzosina
WO2007080509A2 (en) 2006-01-12 2007-07-19 Wockhardt Ltd Sustained release compositions of alfuzosin
US20070292505A1 (en) * 2006-06-15 2007-12-20 Abrika Pharmaceuticals, Inc. Controlled release alfuzosin hydrochloride formulation

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1101649B (it) * 1978-12-15 1985-10-07 Lehner Ag Composizione farmaceutica ad azione prolungata contenente acidi biliari
FR2477015A1 (fr) * 1980-03-03 1981-09-04 Fabre Sa Pierre Composition pharmaceutique a base d'un alcaloide de l'ergot de seigle, a activite regulatrice sur le tonus vasculaire
US4931285A (en) * 1988-04-28 1990-06-05 Alza Corporation Aqueous based pharmaceutical coating composition for dosage forms
DE3822095A1 (de) * 1988-06-30 1990-01-04 Klinge Co Chem Pharm Fab Neue arzneimittelformulierung sowie verfahren zu deren herstellung

Also Published As

Publication number Publication date
GB9523191D0 (en) 1996-01-17
DK0700285T3 (da) 1999-02-15
EP0700285B1 (en) 1998-09-23
GB2292315A (en) 1996-02-21
JPH09504779A (ja) 1997-05-13
NO306759B1 (no) 1999-12-20
EP0700285A1 (en) 1996-03-13
GB9311191D0 (en) 1993-07-14
ES2124889T3 (es) 1999-02-16
DE69413534T2 (de) 1999-03-18
FI955730A (fi) 1996-01-26
GB2292315B (en) 1997-04-02
ATE171370T1 (de) 1998-10-15
CA2163340A1 (en) 1994-12-08
WO1994027582A1 (en) 1994-12-08
DE69413534D1 (de) 1998-10-29
AU684786B2 (en) 1998-01-08
AU6802094A (en) 1994-12-20
FI955730A0 (fi) 1995-11-28
NO954583L (no) 1995-11-14

Similar Documents

Publication Publication Date Title
NO954583L (no) Blanding for oral administrering
DK0817621T3 (da) Filmdannende farmaceutisk præparat til transdermal administration
AU1534699A (en) Osmotic dosage form comprising first and second coats
FI954228A (fi) Infuusiolaite hoitoaineen jaksottaista tai jatkuvaa antamista varten
DE60233898D1 (de) Transdermales therapeutisches system für parkinson-krankheit mit hohen rotigotin-plasmaspiegeln
NO953278D0 (no) Fremgangsmåter for in vivo-levering av biologisk aktive stoffer og sammensetninger som er nyttige for dette
ES2065461T3 (es) Unidades de administracion de un farmaco de liberacion constante.
NO962088L (no) Preparat for in vivo-produksjon av terapeutiske produkter
NO972968L (no) Fremgangsmåte, sammensetninger og sett for öking av oral biotilgjengelighet av farmasöytiske midler
DE69427472D1 (de) Arzneimittel mit kontrollierter Wirkstoffabgabe
DK0730444T3 (da) Præparater med opretholdt frigivelse til 24-timers frigivelse af metoprolol.
CO5130022A1 (es) Sistema de entrega controlado de droga administrado oralmente, que provee control temporal y espacial
CY1106542T1 (el) Μεθοδος για παρασκευη φαρμακευτικων συνθεσεων για χρηση με συνταγοποιησεις μαλακης ζελατινης
AU2002364082A1 (en) Fused heterocyclic compounds and analogs thereof: modulators of nuclear hormone receptor function
AU2084801A (en) Antiviral medication
AU7294196A (en) Stable pharmaceutical forms of administration containing parathormone
ES2132163T3 (es) Composicion farmaceutica de liberacion controlada en forma de suspension liquida.
AU2782592A (en) Thermal enhancement of transdermal drug administration
AU7291996A (en) Transdermal therapeutic system (tts) for the administration of drugs for treatment of drug dependency or drug addiction
ATE276768T1 (de) Arzneimittel gegen hepatitis
AU3690495A (en) Pharmaceutical composition containing derivatives of sex hormones
AU6869996A (en) Use of esters of polyhydric alcohols to enhance the oral bioavailability of drug substances as well as novel esters and pharmaceutical compositions containing them
EA200101157A1 (ru) 14β-H-СТЕРОЛЫ, СОДЕРЖАЩИЕ ИХ ФАРМАЦЕВТИЧЕСКИЕ КОМПОЗИЦИИ И ПРИМЕНЕНИЕ ЭТИХ ПРОИЗВОДНЫХ ДЛЯ ПРИГОТОВЛЕНИЯ ЛЕКАРСТВЕННЫХ СРЕДСТВ, РЕГУЛИРУЮЩИХ МЕЙОЗ
TH35426A (th) สารผสม
IT1269412B (it) Apparecchio distributore di farmaci

Legal Events

Date Code Title Description
MK1K Patent expired